Humulin I 100units/ml suspension for injection 3ml cartridges

Страна: Велика Британія

мова: англійська

Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активний інгредієнт:

Insulin isophane human

Доступна з:

Eli Lilly and Company Ltd

Код атс:

A10AC01

ІПН (Міжнародна Ім'я):

Insulin isophane human

Дозування:

100unit/1ml

Фармацевтична форма:

Suspension for injection

Адміністрація маршрут:

Subcutaneous

Клас:

No Controlled Drug Status

Тип рецепту:

Caution - AMP level prescribing advised

Огляд продуктів:

BNF: 06010102; GTIN: 5014602100759

інформаційний буклет

1
PACKAGE LEAFLET: INFORMATION FOR THE USER
HUMULIN
® I (ISOPHANE) 100 IU/ML SUSPENSION FOR INJECTION IN CARTRIDGE
(Insulin human)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes
any possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Humulin I is and what it is used for
2.
What you need to know before you use Humulin I
3.
How to use Humulin I
4.
Possible side effects
5.
How to store Humulin I
6.
Contents of the pack and other information
1.
WHAT HUMULIN I IS AND WHAT IT IS USED FOR
Humulin I contains the active substance human insulin, which is used
to treat diabetes. You get
diabetes if your pancreas does not make enough insulin to control the
level of glucose in your blood
(blood sugar). Humulin I is used to control glucose in the long term.
Its action is prolonged by the
inclusion of protamine sulfate in the suspension.
Your doctor may tell you to use Humulin I as well as a fast-acting
insulin. Each kind of insulin
comes with its own patient information leaflet to tell you about it.
Do not change your insulin
unless your doctor tells you to. Be very careful if you do change
insulin. Each type of insulin has a
different colour and symbol on the pack and the cartridge so that you
can easily tell the difference.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE HUMULIN I
DO NOT USE HUMULIN I:
-
IF YOU THINK HYPOGLYCAEMIA (LOW BLOOD SUGAR) IS STARTING.
Further in this leaflet it tells
you how to deal with mild hypoglycaemia (
_see A in Section 4_
).
-
If you are allergic to human insulin or any of the other ingredients
of this medicine
(listed

Характеристики продукта

OBJECT 1
HUMULIN I (ISOPHANE) 100IU/ML SUSPENSION FOR
INJECTION IN CARTRIDGE
Summary of Product Characteristics Updated 29-Apr-2018 | Eli Lilly and
Company Limited
1. Name of the medicinal product
Humulin
®
I (Isophane) 100 IU/ml suspension for injection in cartridge.
2. Qualitative and quantitative composition
1 ml contains 100 IU insulin human (produced in _E. coli_ by
recombinant DNA technology).
One cartridge contains 3 ml equivalent to 300 IU of isophane insulin.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
A suspension for injection in a cartridge.
Humulin I is a sterile suspension of a white, crystalline precipitate
of isophane human insulin in an
isotonic phosphate buffer.
4. Clinical particulars
4.1 Therapeutic indications
For the treatment of patients with diabetes mellitus who require
insulin for the maintenance of glucose
homeostasis.
4.2 Posology and method of administration
Posology
The dosage should be determined by the physician, according to the
requirement of the patient.
_Paediatric population_
No data are available
Method of administration
Humulin I should be given by subcutaneous injection but may although
not recommended, also be given
by intramuscular injection. This formulation should not be
administered intravenously.
Subcutaneous administration should be in the upper arms, thighs,
buttocks or abdomen. Use of injection
sites should be rotated so that the same site is not used more than
approximately once a month.
Care should be taken when injecting any Humulin insulin preparations
to ensure that a blood vessel has
not been entered. After any insulin injection, the injection site
should not be massaged. Patients must be
educated to use proper injection techniques.
Each pack contains a patient information leaflet with instructions on
how to inject insulin.
4.3 Contraindications
Hypoglycaemia.
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1, unless used as
part of a desensitisation programme.
Under no circumstances should